Brigatinib Activity in Patients with ALK plus NSCLC and Intracranial CNS Metastases in Two Clinical Trials

被引：4

作者：

Gettinger, Scott ^{[1
]}

Kim, Dong-Wan ^{[2
]}

Tiseo, Marcello ^{[3
]}

Langer, Corey ^{[4
]}

Ahn, Myung-Ju ^{[5
]}

Shaw, Alice ^{[6
]}

Huber, Rudolf ^{[7
]}

Hochmair, Maximilian ^{[8
]}

Kim, Sang-We ^{[9
]}

Bazhenova, Lyudmila ^{[10
]}

Gold, Kathryn ^{[10
]}

Ou, Sai-Hong ^{[11
]}

West, Howard ^{[12
]}

Reichmann, William ^{[13
]}

Haney, Jeff ^{[13
]}

Clackson, Tim ^{[13
]}

Haluska, Frank ^{[13
]}

Kerstein, David ^{[13
]}

Camidge, D. Ross ^{[14
]}

机构：

[1] Yale Canc Ctr, New Haven, CT USA

[2] Seoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea

[3] Univ Hosp Parma, Med Oncol, Parma, Italy

[4] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA

[5] Samsung Med Ctr, Seoul, South Korea

[6] Massachusetts Gen Hosp, Boston, MA 02114 USA

[7] Univ Hosp Munich, Thorac Oncol Ctr Munich, Munich, Germany

[8] Otto Wagner Hosp, Dept Resp & Crit Care Med, Vienna, Austria

[9] Asan Med Ctr, Seoul, South Korea

[10] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA

[11] Univ Calif Irvine, Hlth Chao Family Comprehens Canc Ctr, Orange, CA 92668 USA

[12] Swedish Canc Inst, Seattle, WA USA

[13] ARIAD Pharmaceut Inc, Cambridge, MA 02139 USA

[14] Univ Colorado, Ctr Canc, Denver, CO 80262 USA

来源：

JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 01期

关键词：

NSCLC; TKI; ALK; brigatinib;

D O I：

10.1016/j.jtho.2016.11.271

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

OA08.06

引用

页码：S273 / S274

页数：2